Diabetes, Vol 49, Issue 5 820-826, Copyright © 2000 by American Diabetes Association

ARTICLES

Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia

NC Tkacs, AA Dunn-Meynell and BE Levin
School of Nursing, University of Pennsylvania, Philadelphia, USA.

Hypoglycemia reduces sympathoadrenal responses to subsequent hypoglycemic bouts by an unknown mechanism. To assess whether such hypoglycemia-associated autonomic failure is due to actual brain damage, male Sprague-Dawley rats underwent 1-h bouts of insulin-induced (5 U/kg i.v.) hypoglycemia (1.6-2.8 mmol/l) 1 or 3 times on alternate days. Rats remained alert and were rescued with intravenous glucose at 60-80 min. Plasma epinephrine and corticosterone responses were significantly reduced during the second and third bouts. Brains from these rats were processed by the terminal transferase-mediated deoxyuridine triphosphate-biotin nick end-labeling (TUNEL) procedure as an index of apoptotic cell death at 24, 48, or 96 h after their first bout. At 48 h, but not 24 h, TUNEL+ cells were consistently seen only in the arcuate nucleus (arcuate hypothalamic nucleus [ARC]). Hypoglycemic rats had 188% more apoptotic ARC cells (1 bout 39+/-5; 3 bouts 37+/-4) than euglycemic controls (13+/-3;P = 0.001). In situ hybridization for neuropeptide Y (NPY) and proopiomelanocortin (POMC) mRNA was performed in sections of ARC containing maximal numbers of apoptotic cells as well as in other fresh frozen brains. After 1 bout, NPY (0.041+/-0.003) and POMC (0.119+/-0.022) mRNA were decreased, respectively, by 52 and 55% vs. controls (NPY 0.076+/-0.007; POMC 0.222+/-0.020; P = 0.01). NPY (0.029+/-0.002) but not POMC (0.093+/-0.013) fell 29% further after a third bout. NPY (r = -0.721; P = 0.001) and POMC (r = -0.756; P = 0.001) mRNA levels correlated negatively with the number of apoptotic ARC cells in the same sections. Thus, non-coma hypoglycemia produces apparent apoptotic cell death with reduced NPY and POMC expression selectively in the ARC. This may contribute to the reduced counterregulatory response following repeated bouts of hypoglycemia.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. E. Levin, T. C. Becker, J.-i. Eiki, B. B. Zhang, and A. A. Dunn-Meynell Ventromedial Hypothalamic Glucokinase Is an Important Mediator of the Counterregulatory Response to Insulin-Induced Hypoglycemia Diabetes, May 1, 2008; 57(5): 1371 - 1379. [Abstract] [Full Text] [PDF]

				N. M. Sanders, G. J. Taborsky Jr., C. W. Wilkinson, W. Daumen, and D. P. Figlewicz Antecedent Hindbrain Glucoprivation Does Not Impair the Counterregulatory Response to Hypoglycemia Diabetes, January 1, 2007; 56(1): 217 - 223. [Abstract] [Full Text] [PDF]

				B. E. Levin, L. Kang, N. M. Sanders, and A. A. Dunn-Meynell Role of Neuronal Glucosensing in the Regulation of Energy Homeostasis Diabetes, December 1, 2006; 55(Supplement_2): S122 - S130. [Abstract] [Full Text] [PDF]

				N. C. Tkacs and H. J. Thompson From bedside to bench and back again: research issues in animal models of human disease. Biol Res Nurs, July 1, 2006; 8(1): 78 - 88. [Abstract] [PDF]

				J. A. Herlein, D. A. Morgan, B. G. Phillips, W. G. Haynes, and W. I. Sivitz Antecedent Hypoglycemia, Catecholamine Depletion, and Subsequent Sympathetic Neural Responses Endocrinology, June 1, 2006; 147(6): 2781 - 2788. [Abstract] [Full Text] [PDF]

				L. Kang, A. A. Dunn-Meynell, V. H. Routh, L. D. Gaspers, Y. Nagata, T. Nishimura, J. Eiki, B. B. Zhang, and B. E. Levin Glucokinase Is a Critical Regulator of Ventromedial Hypothalamic Neuronal Glucosensing Diabetes, February 1, 2006; 55(2): 412 - 420. [Abstract] [Full Text] [PDF]

				J. W. Mastaitis, E. Wurmbach, H. Cheng, S. C. Sealfon, and C. V. Mobbs Acute Induction of Gene Expression in Brain and Liver by Insulin-Induced Hypoglycemia Diabetes, April 1, 2005; 54(4): 952 - 958. [Abstract] [Full Text] [PDF]

				J. K. Young and J. C. McKenzie GLUT2 Immunoreactivity in Gomori-positive Astrocytes of the Hypothalamus J. Histochem. Cytochem., November 1, 2004; 52(11): 1519 - 1524. [Abstract] [Full Text] [PDF]

				N. C. Tkacs and B. E. Levin Obesity-prone rats have preexisting defects in their counterregulatory response to insulin-induced hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1110 - R1115. [Abstract] [Full Text] [PDF]

				B. E. Levin, V. H. Routh, L. Kang, N. M. Sanders, and A. A. Dunn-Meynell Neuronal Glucosensing: What Do We Know After 50 Years? Diabetes, October 1, 2004; 53(10): 2521 - 2528. [Abstract] [Full Text] [PDF]

				N. M. Sanders, A. A. Dunn-Meynell, and B. E. Levin Third Ventricular Alloxan Reversibly Impairs Glucose Counterregulatory Responses Diabetes, May 1, 2004; 53(5): 1230 - 1236. [Abstract] [Full Text] [PDF]

				A. A. Dunn-Meynell, V. H. Routh, L. Kang, L. Gaspers, and B. E. Levin Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons Diabetes, July 1, 2002; 51(7): 2056 - 2065. [Abstract] [Full Text] [PDF]

				K. Brusselmans, F. Bono, P. Maxwell, Y. Dor, M. Dewerchin, D. Collen, J.-M. Herbert, and P. Carmeliet Hypoxia-inducible Factor-2alpha (HIF-2alpha ) Is Involved in the Apoptotic Response to Hypoglycemia but Not to Hypoxia J. Biol. Chem., October 12, 2001; 276(42): 39192 - 39196. [Abstract] [Full Text] [PDF]